|
|
| | enadoline Basic information |
| Product Name: | enadoline | | Synonyms: | 4-Benzofuranacetamide, N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-;Cam 569;N-Methyl-N-(7-(1-pyrolidinyl)-1-oxaspiro(4,5)dec-8-yl)-4-benzofuranacetamide;Pd 129289;Enadoline (Free Base) | | CAS: | 107431-28-7 | | MF: | C24H32N2O3 | | MW: | 396.52248 | | EINECS: | | | Product Categories: | | | Mol File: | 107431-28-7.mol |  |
| | enadoline Chemical Properties |
| | enadoline Usage And Synthesis |
| Description | Enadoline (Free Base) is a kappa-opioid receptor agonist; PD 129290 (CAM 570; CI 977) is the S,S(-)-enantiomer; PD 129289 (CAM 569) is the corresponding R,R(+)-enantiomer. In human studies, it produced visual distortions and feelings of dissociation, reminiscent of the effects of salvinorin A. It was studied as a potential analgesic, but abandoned because of the dose-limiting effects of dysphoria, which could be expected from a κ-opioid agonist. There was mention of its potential in treating comatose head injury or stroke victims, where that type of side effect would be immaterial. | | Uses | (Rac)-Enadoline ((Rac)-CI-977 free base) is a selective K-opioid receptor agonist that stereoselectively antagonizes clonic seizures induced by slow intravenous injection of N-methyl-DL-aspartate in mice[1]. | | References | [1] Singh L, et al. The anticonvulsant action of CI-977, a selective κ-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex[J]. European journal of pharmacology, 1990, 191(3): 477-480. |
| | enadoline Preparation Products And Raw materials |
|